180 related articles for article (PubMed ID: 8175026)
1. Analysis of HPV-positive and -negative vulvar carcinomas for alterations in c-myc, Ha-, Ki-, and N-ras genes.
Tate JE; Mutter GL; Prasad CJ; Berkowitz R; Goodman H; Crum CP
Gynecol Oncol; 1994 Apr; 53(1):78-83. PubMed ID: 8175026
[TBL] [Abstract][Full Text] [Related]
2. [Presence of papillomavirus genomes and amplification of the c-myc and C-Ha-ras oncogenes in invasive cancers of the uterine cervix].
Riou G; Barrois M; Tordjman I; Dutronquay V; Orth G
C R Acad Sci III; 1984; 299(14):575-80. PubMed ID: 6097348
[TBL] [Abstract][Full Text] [Related]
3. "Low-risk" and "high-risk" HPV-infection and K-ras gene point mutations in human cervical cancer: a study of 31 cases.
Stenzel A; Semczuk A; Rózyńskal K; Jakowicki J; Wojcierowski J
Pathol Res Pract; 2001; 197(9):597-603. PubMed ID: 11569923
[TBL] [Abstract][Full Text] [Related]
4. Analysis of human papillomavirus infection and molecular alterations in adenocarcinoma of the cervix.
Ferguson AW; Svoboda-Newman SM; Frank TS
Mod Pathol; 1998 Jan; 11(1):11-8. PubMed ID: 9556417
[TBL] [Abstract][Full Text] [Related]
5. A possible role for human papillomaviruses and c-myc, c-Ha-ras, and p53 gene alterations in malignant cutaneous lesions from renal transplant recipients.
Pelisson I; Soler C; Chardonnet Y; Euvrard S; Schmitt D
Cancer Detect Prev; 1996; 20(1):20-30. PubMed ID: 8907200
[TBL] [Abstract][Full Text] [Related]
6. Relationships between c-Ki-ras mutations, HPV types, and prognostic indicators in invasive endocervical adenocarcinomas.
Koulos JP; Wright TC; Mitchell MF; Silva E; Atkinson EN; Richart RM
Gynecol Oncol; 1993 Mar; 48(3):364-9. PubMed ID: 8385060
[TBL] [Abstract][Full Text] [Related]
7. [Ha-ras and p53 gene mutations scanned by PCR-SSCP in premalignant and malignant lesions of the uterine cervix associated with human papillomavirus].
Alonio LV; Dalbert D; Picconi MA; Cervantes Vazquez G; García Carrancá A; Distefano AL; Mural J; Bartt O; Bazan G; Teyssie AR
Medicina (B Aires); 2000; 60(6):895-901. PubMed ID: 11436698
[TBL] [Abstract][Full Text] [Related]
8. [Human papillomaviruses and cellular oncogenes (c-myc, c-Ha-ras) in cutaneous and mucosal lesions in transplantation recipients].
Pélisson I; Soler C; Chignol MC; Euvrard S; Chardonnet Y
Bull Cancer; 1992; 79(5):471-82. PubMed ID: 1330099
[TBL] [Abstract][Full Text] [Related]
9. Status of c-myc, p53 and retinoblastoma genes in human papillomavirus positive and negative squamous cell carcinomas of the anus.
Crook T; Wrede D; Tidy J; Scholefield J; Crawford L; Vousden KH
Oncogene; 1991 Jul; 6(7):1251-7. PubMed ID: 1650445
[TBL] [Abstract][Full Text] [Related]
10. Occurrence of human papillomavirus type 16 DNA sequences and c-myc oncogene alterations in uterine-cervix carcinoma.
Ocádiz R; Sauceda R; Salcedo M; Ortega V; Rodríguez H; Gordillo C; Chávez P; Gariglio P
Arch Invest Med (Mex); 1989; 20(4):355-62. PubMed ID: 2562235
[TBL] [Abstract][Full Text] [Related]
11. Mutations in the p53 gene and human papillomavirus infection as significant prognostic factors in squamous cell carcinomas of the oral cavity.
Chiba I; Shindoh M; Yasuda M; Yamazaki Y; Amemiya A; Sato Y; Fujinaga K; Notani K; Fukuda H
Oncogene; 1996 Apr; 12(8):1663-8. PubMed ID: 8622886
[TBL] [Abstract][Full Text] [Related]
12. Human papilloma virus infection and Ki-ras oncogene in paraffin-embedded squamous carcinomas of the cervix.
Falcinelli C; Luzi P; Alberti P; Cosmi EV; Anceschi MM
Gynecol Obstet Invest; 1993; 36(3):185-8. PubMed ID: 8244195
[TBL] [Abstract][Full Text] [Related]
13. Carcinoma of the vulva: HPV and p53 mutations.
Lee YY; Wilczynski SP; Chumakov A; Chih D; Koeffler HP
Oncogene; 1994 Jun; 9(6):1655-9. PubMed ID: 8183560
[TBL] [Abstract][Full Text] [Related]
14. Abnormal expression of pan-ras, c-myc and tp53 in squamous cell carcinoma of cervix: correlation with HPV and prognosis.
Ngan HY; Cheung AN; Liu SS; Cheng DK; Ng TY; Wong LC
Oncol Rep; 2001; 8(3):557-61. PubMed ID: 11295080
[TBL] [Abstract][Full Text] [Related]
15. Second genital primary squamous neoplasms in vulvar carcinoma: viral and histopathologic correlates.
Mitchell MF; Prasad CJ; Silva EG; Rutledge FN; McArthur MC; Crum CP
Obstet Gynecol; 1993 Jan; 81(1):13-8. PubMed ID: 8380102
[TBL] [Abstract][Full Text] [Related]
16. Genetic alterations of c-myc, c-erbB-2, and c-Ha-ras protooncogenes and clinical associations in human breast carcinomas.
Garcia I; Dietrich PY; Aapro M; Vauthier G; Vadas L; Engel E
Cancer Res; 1989 Dec; 49(23):6675-9. PubMed ID: 2573420
[TBL] [Abstract][Full Text] [Related]
17. Genetic abnormalities and HPV status in cervical and vulvar squamous cell carcinomas.
Huang FY; Kwok YK; Lau ET; Tang MH; Ng TY; Ngan HY
Cancer Genet Cytogenet; 2005 Feb; 157(1):42-8. PubMed ID: 15676146
[TBL] [Abstract][Full Text] [Related]
18. Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection.
Kuzmin I; Liu L; Dammann R; Geil L; Stanbridge EJ; Wilczynski SP; Lerman MI; Pfeifer GP
Cancer Res; 2003 Apr; 63(8):1888-93. PubMed ID: 12702579
[TBL] [Abstract][Full Text] [Related]
19. Decreased survival in EGFR gene amplified vulvar carcinoma.
Growdon WB; Boisvert SL; Akhavanfard S; Oliva E; Dias-Santagata DC; Kojiro S; Horowitz NS; Iafrate AJ; Borger DR; Rueda BR
Gynecol Oncol; 2008 Nov; 111(2):289-97. PubMed ID: 18768215
[TBL] [Abstract][Full Text] [Related]
20. Lack of synergistic association between human papillomavirus and ras gene point mutation in laryngeal carcinomas.
Shidara K; Suzuki T; Hara F; Nakajima T
Laryngoscope; 1994 Aug; 104(8 Pt 1):1008-12. PubMed ID: 8052064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
